WALDENCAST PLC (WALD)
Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel
MNTN, INC. CLASS A COMMON STOCK (MNTN)
MNTN Brings Advanced Data Attribution to CTV with First of its Kind HubSpot Integration
CUPRINA HOLDINGS (CAYMAN) LTD (CUPR)
Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots — the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product
XBIOTECH INC. (XBIT)
XBiotech lance un essai clinique de phase II visant à évaluer le vilamakitug dans le traitement de la spondylarthrite axiale active
WESTERN ALLIANCE BANCORPORATION (WAL)
Western Alliance Appoints CEO Kenneth Vecchione as Chairman
OPKO HEALTH,INC. (OPK)
Preclinical Data for OPKO Biologics OPK8801001 in Acromegaly Presented at ENDO 2026
LPL FINANCIAL HOLDINGS INC. (LPLA)
LPL Financial Welcomes Fortress Financial Planning
Elanco Animal Health Incorporated (ELAN)
Elanco Animal Health Inc. - Elanco Announces USDA Approval ofTruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs
Elanco Animal Health Incorporated (ELAN)
Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs
ELANCO ANIMAL HEALTH INC (ELAN)
Elanco Announces USDA Approval of TruCan™ Ultra Lyme-L4, the First and Only 1/2 mL Combination Vaccine for Lyme and Leptospirosis for Dogs